Liberty Mutual Group Asset Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Liberty Mutual Group Asset Management Inc.

  • $660 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $1.04 Million - $1.25 Million
-3,092 Closed
0 $0
Q2 2018

Aug 10, 2018
BUY
$284.6 - $344.99 $8,538 - $10,349
30 Added 0.98%
3,092 $1.07 Million
Q4 2017

Feb 12, 2018
SELL
$358.63 - $469.95 $8,607 - $11,278
-24 Reduced 0.78%
3,062 $1.15 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $1.33 Million - $1.56 Million
3,086
3,086 $1.38 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Liberty Mutual Group Asset Management Inc. Portfolio

Follow Liberty Mutual Group Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Mutual Group Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Mutual Group Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email